期刊
PEDIATRIC DERMATOLOGY
卷 30, 期 6, 页码 751-752出版社
WILEY-BLACKWELL
DOI: 10.1111/pde.12229
关键词
-
资金
- NCATS NIH HHS [UL1 TR000055] Funding Source: Medline
- NHLBI NIH HHS [T35 HL072483] Funding Source: Medline
Historically the first line of treatment for infantile hemangiomas (IHs) has been oral corticosteroids, but because of recent discoveries recognizing the effectiveness of oral and topical beta-blockers, IH management is dynamically changing. With these new treatment options, some physicians are altering the way they manage IHs despite having little evidence-based data on the treatment methods. Highlighting treatment changes at a single large tertiary pediatric referral center, we conclude that despite the numerous studies already published on this topic, more reliable prospective studies are needed to determine the safety, efficacy, and best treatment algorithms for the use of topical and oral beta-blockers for the treatment of IHs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据